Drug Profile
Research programme: androgen receptor antagonists - Chugai
Alternative Names: CH 5137291; CH-4892789; CH-4892880; CH-4933468; CH4892280Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class Imidazolidines; Nitriles; Pyridines; Sulfonamides
- Mechanism of Action Androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Japan (PO)
- 19 Nov 2009 Pharmacodynamics and pharmacokinetics data from preclinical studies in Cancer presented at the 21st AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2009) ,
- 16 Aug 2009 Pharmacodynamics data from a preclinical trial in cancer presented at the 238th American Chemical Society National Meeting (238th-ACS-2009)